Network‐based recruitment of people who inject drugs for hepatitis C testing and linkage to care
O Falade‐Nwulia, KM Ward, S McCormick… - Journal of viral …, 2020 - Wiley Online Library
Although oral direct‐acting agent (DAA) therapies have the potential to reduce the burden of
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care
O Falade-Nwulia, KM Ward… - Journal of viral …, 2020 - pure.johnshopkins.edu
Although oral direct-acting agent (DAA) therapies have the potential to reduce the burden of
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care
O Falade-Nwulia, KM Ward, S Mccormick… - Journal of Viral …, 2020 - hero.epa.gov
Although oral direct-acting agent (DAA) therapies have the potential to reduce the burden of
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care.
O Falade-Nwulia, KM Ward, S McCormick… - Journal of Viral …, 2020 - europepmc.org
Although oral direct acting agents (DAA) therapies have the potential to reduce the burden
of hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
of hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care.
O Falade-Nwulia, KM Ward, S McCormick, SH Mehta… - 2020 - cabidigitallibrary.org
Although oral direct-acting agent (DAA) therapies have the potential to reduce the burden of
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
[PDF][PDF] Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care
O Falade-Nwulia, KM Ward, S McCormick, SH Mehta… - J Viral Hepat, 2020 - academia.edu
Although oral direct acting agents (DAA) therapies have the potential to reduce the burden
of hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
of hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care
O Falade-Nwulia, KM Ward… - Journal of viral …, 2020 - pubmed.ncbi.nlm.nih.gov
Although oral direct-acting agent (DAA) therapies have the potential to reduce the burden of
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
[HTML][HTML] Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care
O Falade-Nwulia, KM Ward, S McCormick… - Journal of viral …, 2020 - ncbi.nlm.nih.gov
Although oral direct acting agents (DAA) therapies have the potential to reduce the burden
of hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …
of hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …